Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03558139
Title A Trial of Hu5F9-G4 With Avelumab in Ovarian Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Forty Seven, Inc.
Indications

fallopian tube cancer

peritoneum cancer

Advanced Solid Tumor

ovary epithelial cancer

Therapies

Avelumab + Hu5F9-G4

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.